6533b854fe1ef96bd12aeaaa
RESEARCH PRODUCT
Impact of the Hypoechogenicity Criteria on Thyroid Nodule Malignancy Risk Stratification Performance by Different TIRADS Systems
Kaspars StepanovsNina Malika PopovaMara LiepaMadara RaudaMaija RadzinaPeteris Prieditissubject
Thyroid nodulesCancer Researchmedicine.medical_specialtyBethesda systemMalignancyArticleBiopsymedicinefine-needle aspiration biopsyRC254-282medicine.diagnostic_testbusiness.industryultrasoundTIRADSThyroidEchogenicityNeoplasms. Tumors. Oncology. Including cancer and carcinogensNodule (medicine)medicine.diseasemedicine.anatomical_structureFine-needle aspirationOncologythyroid noduleRadiologymedicine.symptombusinessdescription
Background: Various Thyroid Imaging and Reporting data systems (TIRADS) are used worldwide for risk stratification of thyroid nodules. Their sensitivity is high, while the specificity is suboptimal. The aim of the study was to compare several TIRADS systems and evaluate the effect of hypoechogenicity as a sign of risk of malignancy on the overall assessment of diagnostic accuracy. Methods: The prospective study includes 274 patients with 289 thyroid nodules to whom US and risk of malignancy were assessed according to four TIRADS systems—European (EU-TIRADS), Korean (K-TIRADS), TIRADS by American College of Radiology (ACR TIRADS), and modified Kwak et al. TIRADS (L-TIRADS) systems, in which mild hypoechogenicity is not included in malignancy risk suggestive signs. For all thyroid nodules, a fine needle aspiration (FNA) biopsy was performed and evaluated according to the Bethesda system. For all systems, diagnostic accuracy was calculated. Results: Assessing the echogenicity of the thyroid nodules: from 81 of isoechogenic nodules, 2 were malignant (2.1%), from 151 mild hypoechogenic, 18 (12%) were malignant, and from 48 marked hypoechogenic nodules, 16 (33%) were malignant. In 80 thyroid nodules, mild hypoechogenicity was the only sign of malignancy and none appeared malignant. Assessing various TIRADS systems on the same cohort, sensitivity, specificity, PPV, NPV, and accuracy, firstly for EU-TIRADS, they were 97.2%
year | journal | country | edition | language |
---|---|---|---|---|
2021-11-01 | Cancers |